Aetna Inc. (AET) To Go Ex-Dividend on October 11th
Aetna Inc. (NYSE:AET) announced a quarterly dividend on Friday, September 30th. Shareholders of record on Thursday, October 13th will be paid a dividend of 0.25 per share on Friday, October 28th. This represents a $1.00 annualized dividend and a yield of 0.87%. The ex-dividend date is Tuesday, October 11th.
Shares of Aetna (NYSE:AET) opened at 114.98 on Thursday. The firm has a 50-day moving average of $116.49 and a 200 day moving average of $115.79. The company has a market capitalization of $40.33 billion, a PE ratio of 16.85 and a beta of 0.54. Aetna has a 12 month low of $92.42 and a 12 month high of $123.57.
Aetna (NYSE:AET) last issued its earnings results on Tuesday, August 2nd. The company reported $2.21 EPS for the quarter, beating analysts’ consensus estimates of $2.12 by $0.09. The business earned $15.95 billion during the quarter, compared to analyst estimates of $15.69 billion. Aetna had a return on equity of 16.44% and a net margin of 3.89%. Aetna’s revenue was up 4.7% on a year-over-year basis. During the same period in the prior year, the company posted $2.05 earnings per share. On average, equities research analysts expect that Aetna will post $8.05 earnings per share for the current fiscal year.
In other Aetna news, insider Shawn M. Guertin sold 45,328 shares of the stock in a transaction dated Tuesday, August 23rd. The stock was sold at an average price of $120.21, for a total value of $5,448,878.88. Following the transaction, the insider now owns 44,883 shares of the company’s stock, valued at $5,395,385.43. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jeffrey E. Garten sold 7,100 shares of the stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total value of $827,221.00. The disclosure for this sale can be found here. 0.90% of the stock is owned by company insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. Capital International Investors raised its position in Aetna by 7.5% in the second quarter. Capital International Investors now owns 4,650,500 shares of the company’s stock valued at $567,966,000 after buying an additional 324,000 shares during the last quarter. APG Asset Management N.V. raised its position in Aetna by 34.6% in the second quarter. APG Asset Management N.V. now owns 641,470 shares of the company’s stock valued at $78,343,000 after buying an additional 165,000 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp raised its position in Aetna by 10.2% in the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 949,612 shares of the company’s stock valued at $115,976,000 after buying an additional 88,010 shares during the last quarter. Laurion Capital Management LP raised its position in Aetna by 2,084.6% in the second quarter. Laurion Capital Management LP now owns 69,906 shares of the company’s stock valued at $8,538,000 after buying an additional 66,706 shares during the last quarter. Finally, Franklin Resources Inc. raised its position in Aetna by 6.9% in the second quarter. Franklin Resources Inc. now owns 1,016,120 shares of the company’s stock valued at $124,099,000 after buying an additional 65,911 shares during the last quarter. 91.95% of the stock is currently owned by hedge funds and other institutional investors.
A number of research analysts recently commented on the company. Leerink Swann restated a “buy” rating and issued a $135.00 target price on shares of Aetna in a research note on Thursday, August 4th. Zacks Investment Research lowered Aetna from a “buy” rating to a “hold” rating in a research note on Monday, August 8th. Morgan Stanley restated a “buy” rating on shares of Aetna in a research note on Tuesday, June 14th. FBR & Co restated a “hold” rating on shares of Aetna in a research note on Wednesday, August 17th. Finally, Wolfe Research lowered Aetna from an “outperform” rating to a “peer perform” rating in a research note on Thursday, July 21st. Six equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Aetna presently has an average rating of “Buy” and a consensus price target of $132.43.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.